Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 1.680
-0.075 (-4.27%)
At close: Jun 11, 2025
Bio-Works Technologies AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 28.51 | 25.47 | 43.9 | 41.32 | 21.91 | 7.23 | Upgrade
|
| Other Revenue | 4.31 | 5.02 | - | - | 34.45 | - | Upgrade
|
| Revenue | 32.82 | 30.49 | 43.9 | 41.32 | 56.36 | 7.23 | Upgrade
|
| Revenue Growth (YoY) | -17.17% | -30.55% | 6.23% | -26.68% | 679.09% | 29.83% | Upgrade
|
| Cost of Revenue | 5.6 | 5.45 | 17.08 | 12.47 | 3.35 | 3.02 | Upgrade
|
| Gross Profit | 27.22 | 25.04 | 26.82 | 28.85 | 53.01 | 4.22 | Upgrade
|
| Selling, General & Admin | 57.99 | 60.2 | 81.63 | 74.95 | 62.5 | 49.44 | Upgrade
|
| Other Operating Expenses | 0.17 | 0.12 | 2.09 | 0.57 | 0.76 | -0.27 | Upgrade
|
| Operating Expenses | 58.66 | 60.83 | 84.33 | 75.99 | 63.97 | 49.87 | Upgrade
|
| Operating Income | -31.44 | -35.8 | -57.5 | -47.14 | -10.96 | -45.65 | Upgrade
|
| Interest Expense | -0.29 | -0.01 | -0 | -0.02 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.36 | 0.6 | 0.88 | 0.35 | 0.07 | 0.11 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.93 | 0.93 | 1.89 | 2.12 | 1.53 | -0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | 0 | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | -30.44 | -34.28 | -54.73 | -44.7 | -9.37 | -45.76 | Upgrade
|
| Merger & Restructuring Charges | -3 | -3 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.74 | Upgrade
|
| Pretax Income | -33.44 | -37.28 | -54.73 | -44.7 | -9.37 | -45.02 | Upgrade
|
| Income Tax Expense | 0.04 | 0.08 | 2.09 | 0.26 | 3.57 | - | Upgrade
|
| Net Income | -33.48 | -37.36 | -56.82 | -44.95 | -12.94 | -45.02 | Upgrade
|
| Net Income to Common | -33.48 | -37.36 | -56.82 | -44.95 | -12.94 | -45.02 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 50 | 36 | 35 | 31 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 50 | 36 | 35 | 31 | 30 | Upgrade
|
| Shares Change (YoY) | 61.11% | 38.31% | 3.16% | 12.17% | 2.60% | 0.50% | Upgrade
|
| EPS (Basic) | -0.56 | -0.75 | -1.57 | -1.28 | -0.41 | -1.48 | Upgrade
|
| EPS (Diluted) | -0.56 | -0.75 | -1.57 | -1.28 | -0.41 | -1.48 | Upgrade
|
| Free Cash Flow | -35.27 | -43.18 | -59.85 | -41 | -14.31 | -43.69 | Upgrade
|
| Free Cash Flow Per Share | -0.59 | -0.86 | -1.66 | -1.17 | -0.46 | -1.44 | Upgrade
|
| Gross Margin | 82.93% | 82.13% | 61.10% | 69.81% | 94.06% | 58.28% | Upgrade
|
| Operating Margin | -95.81% | -117.42% | -131.00% | -114.09% | -19.44% | -631.10% | Upgrade
|
| Profit Margin | -102.02% | -122.54% | -129.45% | -108.78% | -22.96% | -622.33% | Upgrade
|
| Free Cash Flow Margin | -107.46% | -141.63% | -136.34% | -99.23% | -25.39% | -603.88% | Upgrade
|
| EBITDA | -30.94 | -35.28 | -56.89 | -46.67 | -10.47 | -45.5 | Upgrade
|
| EBITDA Margin | -94.27% | -115.73% | -129.61% | -112.95% | -18.57% | - | Upgrade
|
| D&A For EBITDA | 0.51 | 0.51 | 0.61 | 0.47 | 0.49 | 0.15 | Upgrade
|
| EBIT | -31.44 | -35.8 | -57.5 | -47.14 | -10.96 | -45.65 | Upgrade
|
| EBIT Margin | -95.81% | -117.41% | -131.00% | -114.09% | -19.44% | - | Upgrade
|
| Revenue as Reported | 35.2 | 32.94 | 46.7 | 43.01 | 58.82 | 6.68 | Upgrade
|
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.